Annual Shareholders Equity
$344.35 M
+$23.61 M+7.36%
December 31, 2023
Summary
- As of February 28, 2025, JANX annual stockholders equity is $344.35 million, with the most recent change of +$23.61 million (+7.36%) on December 31, 2023.
- During the last 3 years, JANX annual shareholders equity has risen by +$358.99 million (+2452.43%).
- JANX annual shareholders equity is now -6.00% below its all-time high of $366.33 million, reached on December 31, 2021.
Performance
JANX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$656.10 M
-$1.57 M-0.24%
September 30, 2024
Summary
- As of February 28, 2025, JANX quarterly stockholders equity is $656.10 million, with the most recent change of -$1.57 million (-0.24%) on September 30, 2024.
- Over the past year, JANX quarterly shareholders equity has increased by +$307.16 million (+88.02%).
- JANX quarterly shareholders equity is now -0.24% below its all-time high of $657.68 million, reached on June 30, 2024.
Performance
JANX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
JANX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.4% | +88.0% |
| 3 y3 years | +2452.4% | +74.2% |
| 5 y5 years | +4434.7% | - |
JANX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.0% | +7.4% | -0.2% | +119.1% |
| 5 y | 5-year | -6.0% | +2452.4% | -0.2% | +4012.1% |
| alltime | all time | -6.0% | +2452.4% | -0.2% | +4012.1% |
Janux Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $656.10 M(-0.2%) |
| Jun 2024 | - | $657.68 M(+0.3%) |
| Mar 2024 | - | $655.76 M(+90.4%) |
| Dec 2023 | $344.35 M(+7.4%) | $344.35 M(-1.3%) |
| Sep 2023 | - | $348.95 M(+16.5%) |
| Jun 2023 | - | $299.47 M(-3.8%) |
| Mar 2023 | - | $311.26 M(-3.0%) |
| Dec 2022 | $320.74 M | $320.74 M(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $331.51 M(-3.6%) |
| Jun 2022 | - | $343.81 M(-3.4%) |
| Mar 2022 | - | $356.08 M(-2.8%) |
| Dec 2021 | $366.33 M(-2602.6%) | $366.33 M(-2.8%) |
| Sep 2021 | - | $376.75 M(-2.1%) |
| Jun 2021 | - | $384.80 M(-2394.4%) |
| Mar 2021 | - | -$16.77 M(+14.6%) |
| Dec 2020 | -$14.64 M(+84.3%) | -$14.64 M |
| Dec 2019 | -$7.94 M | - |
FAQ
- What is Janux Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Janux Therapeutics?
- What is Janux Therapeutics annual shareholders equity year-on-year change?
- What is Janux Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Janux Therapeutics?
- What is Janux Therapeutics quarterly shareholders equity year-on-year change?
What is Janux Therapeutics annual stockholders equity?
The current annual shareholders equity of JANX is $344.35 M
What is the all time high annual shareholders equity for Janux Therapeutics?
Janux Therapeutics all-time high annual stockholders equity is $366.33 M
What is Janux Therapeutics annual shareholders equity year-on-year change?
Over the past year, JANX annual stockholders equity has changed by +$23.61 M (+7.36%)
What is Janux Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of JANX is $656.10 M
What is the all time high quarterly shareholders equity for Janux Therapeutics?
Janux Therapeutics all-time high quarterly stockholders equity is $657.68 M
What is Janux Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, JANX quarterly stockholders equity has changed by +$307.16 M (+88.02%)